0001437749-24-003792.txt : 20240212
0001437749-24-003792.hdr.sgml : 20240212
20240212174315
ACCESSION NUMBER: 0001437749-24-003792
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220325
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Dong
CENTRAL INDEX KEY: 0001920163
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24621606
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA, LTD.
STREET 2: 400 ALEXANDER PARK DRIVE, 4TH FLOOR
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4/A
1
rdgdoc.xml
FORM 4/A
X0508
4/A
2022-03-25
2022-03-29
0001668243
UroGen Pharma Ltd.
URGN
0001920163
Kim Dong
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Financial Officer
0
Stock Option (right to buy)
8.61
2022-03-25
4
A
0
20000
0
A
2032-03-25
Ordinary Shares
20000
20000
D
One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025.
This amendment corrects and restates the number of derivative securities acquired reported in the original Form 4 filed on March 29, 2022.
This amendment corrects and restates the expiration date reported in the original Form 4 filed on March 29, 2022.
This amendment corrects and restates the amount of securities underlying derivative security reported in the original Form 4 filed on March 29, 2022.
This amendment corrects and restates the number of derivative securities beneficially owned following reported transaction reported in the original Form 4 filed on March 29, 2022.
/s/ Jason D. Smith, Attorney-in-Fact
2024-02-12